Changes in FDA Policy on Vaping Products
The FDA has a history of hesitance when it comes to allowing access to life-saving products. Under the Biden administration, the FDA turned down over a million applications for flavored vaping products, which many smokers find useful in their efforts to quit cigarettes. Interestingly, the agency hasn’t quite matched the deregulatory momentum expected during Trump’s tenure.
But it seems things are shifting. Recently, the FDA granted marketing authorization for Glas electronic cigarettes, which are made in Los Angeles and come in flavors like mango, blueberry, and various menthol options. Moreover, the FDA announced it would prioritize enforcement against harm reduction products only for those with pending or accepted applications that contain necessary data for health evaluation, especially for non-tobacco flavored products.
This development, along with the recent positive outcomes for reduced-risk heat-not-burn devices, is encouraging for the millions of smokers looking for safer alternatives. It’s crucial that the next Commissioner continues this trend, providing greater options for those wanting to quit smoking altogether. The FDA needs to keep approving new products and step back from its previous restrictive policies.
For around 30 million smokers in the U.S., quitting is a daunting challenge. It is seldom a straightforward or enjoyable process. Even relatively effective methods like nicotine patches have a success rate of less than 20 percent after six months. Earl Chinnici, who battled a 28-year addiction, reflects on his struggle by saying he hadn’t been fair to himself or those around him by keeping cigarettes so close. In his book, Maybe You Should Move Those Away From You, he emphasizes the importance of knowledge as a powerful tool in beating addiction.
Reduced-risk products designed to help smokers transition away from cigarettes are both safe and effective. A report from the National Academies of Sciences in 2018 noted that fully substituting e-cigarettes for traditional cigarettes reduces exposure to various harmful substances. This is even better for families, as studies show lower second-hand exposure from e-cigarettes compared to combustible tobacco.
Numerous studies have shown that e-cigarettes are far more effective than traditional quit-smoking therapies, being about 95 percent safer than cigarettes. Flavors play a vital role in this transition, making quitting more appealing. It’s not surprising, then, that flavor bans can actually lead to an increase in cigarette smoking by making the quitting experience less enjoyable.
Up to this point, FDA officials seemed hesitant to consider current research. They made it clear to vaping companies that having airtight marketing strategies to prevent youth access was essential for approval. Yet, when faced with an influx of product applications, the FDA shifted their stance, allegedly ignoring those marketing plans and focusing instead on statistical evidence regarding the switch from cigarettes to vapes.
This inconsistency resulted in criticism in courts for being “arbitrary and capricious,” which means acting without a reasonable basis. Unfortunately, the Supreme Court sided with the FDA in the FDA v. Triton Distribution case, though they did acknowledge some of the constitutional concerns raised by arguments against anti-vaping laws.
It seems that positive changes may finally be on the horizon for smokers, even without any significant intervention from the Supreme Court. Let’s hope this progress continues for the sake of those who rely on safer alternatives.
